144 related articles for article (PubMed ID: 33966521)
21. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
[TBL] [Abstract][Full Text] [Related]
22. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
23. A multicomponent complex intervention for supportive follow-up of persons with chronic heart failure: a randomized controlled pilot study (the UTILE project).
Schäfer-Keller P; Graf D; Denhaerynck K; Santos GC; Girard J; Verga ME; Tschann K; Menoud G; Kaufmann AL; Leventhal M; Richards DA; Strömberg A
Pilot Feasibility Stud; 2023 Jun; 9(1):106. PubMed ID: 37370176
[TBL] [Abstract][Full Text] [Related]
24. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
[TBL] [Abstract][Full Text] [Related]
25. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry.
Kapelios CJ; Laroche C; Crespo-Leiro MG; Anker SD; Coats AJS; Díaz-Molina B; Filippatos G; Lainscak M; Maggioni AP; McDonagh T; Mebazaa A; Metra M; Moura B; Mullens W; Piepoli MF; Rosano GMC; Ruschitzka F; Seferovic PM; Lund LH;
Eur J Heart Fail; 2020 Aug; 22(8):1424-1437. PubMed ID: 32237110
[TBL] [Abstract][Full Text] [Related]
26. Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial).
Martín-Lesende I; Orruño E; Bilbao A; Vergara I; Cairo MC; Bayón JC; Reviriego E; Romo MI; Larrañaga J; Asua J; Abad R; Recalde E
BMC Health Serv Res; 2013 Mar; 13():118. PubMed ID: 23537332
[TBL] [Abstract][Full Text] [Related]
27. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
[TBL] [Abstract][Full Text] [Related]
28. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
29. Lung ultrasound-guided treatment in ambulatory patients with heart failure: a randomized controlled clinical trial (LUS-HF study).
Rivas-Lasarte M; Álvarez-García J; Fernández-Martínez J; Maestro A; López-López L; Solé-González E; Pirla MJ; Mesado N; Mirabet S; Fluvià P; Brossa V; Sionis A; Roig E; Cinca J
Eur J Heart Fail; 2019 Dec; 21(12):1605-1613. PubMed ID: 31667987
[TBL] [Abstract][Full Text] [Related]
30. Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial.
Aliti GB; Rabelo ER; Clausell N; Rohde LE; Biolo A; Beck-da-Silva L
JAMA Intern Med; 2013 Jun; 173(12):1058-64. PubMed ID: 23689381
[TBL] [Abstract][Full Text] [Related]
31. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.
Barsuk JH; Gordon RA; Cohen ER; Cotts WG; Malkenson D; Yancy CW; Williams MV
Congest Heart Fail; 2013; 19(2):53-60. PubMed ID: 23336425
[TBL] [Abstract][Full Text] [Related]
32. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
[TBL] [Abstract][Full Text] [Related]
33. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
34. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
[TBL] [Abstract][Full Text] [Related]
35. Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure.
Laliberte B; Reed BN; Devabhakthuni S; Watson K; Ivaturi V; Liu T; Gottlieb SS
J Card Fail; 2017 Oct; 23(10):746-752. PubMed ID: 28688888
[TBL] [Abstract][Full Text] [Related]
36. Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience.
Teo LY; Lim CP; Neo CL; Teo LW; Ng SL; Chan LL; Kaushik M; Sim KL
Singapore Med J; 2016 Jul; 57(7):378-83. PubMed ID: 26778634
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after implementing a heart failure diuretic pathway in an emergency department setting.
Bogner S; Bena JF; Morrison SL; Albert NM
Heart Lung; 2023; 57():250-256. PubMed ID: 36332348
[TBL] [Abstract][Full Text] [Related]
38. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
39. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
[TBL] [Abstract][Full Text] [Related]
40. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
